EZH2 and hepatocellular carcinoma: A previous report revealed that the zeste homolog 2 (EZH2) enhancer could promote HCC motility in vitro and pulmonary metastasis in a nude mouse model through epigenetically suppressing miR-139-5p by potent and extensive regulation of various signaling pathways involved in cell motility and metastasis 52.